Chronic inflammation, Adverse Outcome Pathways, and risk assessment: A diagrammatic exposition.
Cox LA, Goodman JE, Engel AM. Chronic inflammation, Adverse Outcome Pathways, and risk assessment: A diagrammatic exposition. Regul Toxicol Pharmacol. 2020 Jul; 114:104663.